Arrow Mark Colorado Holdings LLC Axogen, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

$6.65 Billion
Q4 2024

A detailed history of Arrow Mark Colorado Holdings LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 2,248,792 shares of AXGN stock, worth $45.2 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

2,248,792

Previous 2,275,463 1.17%

Holding current value

$45.2 Million

Previous $31.9 Million 16.17%

% of portfolio

0.56%

Previous 0.45%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$12.47 - $17.19 $332,587 - $458,474	-26,671 Reduced 1.17%	2,248,792 $37.1 Million
Q3 2024 Nov 14, 2024	SELL	$7.52 - $14.69 $21.4 Million - $41.7 Million	-2,841,088 Reduced 55.53%	2,275,463 $31.9 Million
Q2 2024 Aug 14, 2024	BUY	$5.67 - $8.06 $2.21 Million - $3.14 Million	389,831 Added 8.25%	5,116,551 $37 Million
Q1 2024 May 15, 2024	SELL	$6.63 - $10.69 $2.82 Million - $4.55 Million	-425,580 Reduced 8.26%	4,726,720 $38.1 Million
Q4 2023 Feb 14, 2024	BUY	$3.61 - $7.76 $4.44 Million - $9.55 Million	1,231,267 Added 31.4%	5,152,300 $35.2 Million
Q2 2023 Aug 14, 2023	BUY	$8.5 - $10.38 $2.24 Million - $2.73 Million	263,422 Added 7.2%	3,921,033 $35.8 Million
Q1 2023 May 15, 2023	BUY	$7.53 - $10.95 $826,974 - $1.2 Million	109,824 Added 3.1%	3,657,611 $34.6 Million
Q4 2022 Feb 14, 2023	SELL	$9.44 - $13.09 $12.2 Million - $16.9 Million	-1,294,479 Reduced 26.73%	3,547,787 $35.4 Million
Q3 2022 Nov 14, 2022	SELL	$8.14 - $12.25 $6.87 Million - $10.3 Million	-844,422 Reduced 14.85%	4,842,266 $57.7 Million
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $557,501 - $797,570	-79,757 Reduced 1.38%	5,686,688 $46.6 Million
Q1 2022 May 16, 2022	BUY	$7.26 - $10.7 $767,135 - $1.13 Million	105,666 Added 1.87%	5,766,445 $45.8 Million
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $1.54 Million - $2.79 Million	174,550 Added 3.18%	5,660,779 $53 Million
Q3 2021 Nov 15, 2021	BUY	$15.23 - $21.72 $2.4 Million - $3.42 Million	157,504 Added 2.96%	5,486,229 $86.7 Million
Q2 2021 Aug 16, 2021	SELL	$17.8 - $23.5 $10.1 Million - $13.3 Million	-566,993 Reduced 9.62%	5,328,725 $115 Million
Q1 2021 May 17, 2021	SELL	$17.18 - $22.6 $12.4 Million - $16.3 Million	-722,541 Reduced 10.92%	5,895,718 $119 Million
Q4 2020 Feb 16, 2021	BUY	$11.5 - $17.96 $317,802 - $496,324	27,635 Added 0.42%	6,618,259 $118 Million
Q3 2020 Nov 16, 2020	SELL	$10.62 - $13.12 $1.44 Million - $1.78 Million	-135,685 Reduced 2.02%	6,590,624 $76.6 Million
Q2 2020 Aug 14, 2020	BUY	$7.35 - $10.81 $2.92 Million - $4.29 Million	397,136 Added 6.27%	6,726,309 $62.2 Million
Q1 2020 May 15, 2020	BUY	$8.38 - $17.34 $2.94 Million - $6.08 Million	350,595 Added 5.86%	6,329,173 $65.8 Million
Q4 2019 Feb 14, 2020	BUY	$11.18 - $18.6 $6.65 Million - $11.1 Million	594,752 Added 11.05%	5,978,578 $107 Million
Q3 2019 Nov 14, 2019	BUY	$12.09 - $20.46 $17.1 Million - $28.9 Million	1,413,385 Added 35.6%	5,383,826 $67.2 Million
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $6.54 Million - $9.01 Million	353,557 Added 9.78%	3,970,441 $78.6 Million
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $8.03 Million - $12.1 Million	548,906 Added 17.89%	3,616,884 $76.2 Million
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $22.3 Million - $49.8 Million	1,302,765 Added 73.8%	3,067,978 $62.7 Million
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $25.7 Million - $42.1 Million	753,811 Added 74.53%	1,765,213 $65 Million
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $9.83 Million - $14.3 Million	-271,994 Reduced 21.19%	1,011,402 $50.8 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $31.3 Million - $51.7 Million	1,283,396 New	1,283,396 $46.8 Million

Others Institutions Holding AXGN

# of Institutions

179

Shares Held

36.2M

Call Options Held

82.6K

Put Options Held

1.1K

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $850M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account

Arrow Mark Colorado Holdings LLC Axogen, Inc. Transaction History